Abstract: The present disclosure is directed to individual peptide immunogen constructs targeting portions of the Tau protein for the treatment and/or prevention of tauopathies. The present disclosure is also directed to compositions containing the peptide immunogen constructs, methods of making and using the peptide immunogen constructs, and antibodies produced by the peptide immunogen constructs.
Type:
Grant
Filed:
October 26, 2018
Date of Patent:
October 3, 2023
Assignees:
UNITED NEUROSCIENCE, UNS IP HOLDINGS, LLC